CELLULAR AND MOLECULAR LIFE SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向：分子生物 经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801542, encodeId=94fd8015426a, content=我的15天了，还是submitted to the journal。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171966389, createdName=小张～医生, createdTime=Mon Jul 06 23:46:57 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=)]

2022-11-09 ms3000001732307962

偏重的研究方向：分子生物
经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向：分子生物 经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801542, encodeId=94fd8015426a, content=我的15天了，还是submitted to the journal。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171966389, createdName=小张～医生, createdTime=Mon Jul 06 23:46:57 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=)]

2022-11-12 小甜甜66

中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的

56 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向：分子生物 经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801542, encodeId=94fd8015426a, content=我的15天了，还是submitted to the journal。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171966389, createdName=小张～医生, createdTime=Mon Jul 06 23:46:57 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=)]

2018-10-19 yu0608

请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表::
我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表:
我投过去快3周了，还是With ethor，有大神知道什么情况吗？

ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？

237 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向：分子生物 经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801542, encodeId=94fd8015426a, content=我的15天了，还是submitted to the journal。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171966389, createdName=小张～医生, createdTime=Mon Jul 06 23:46:57 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=)]

2022-01-25 NJMU-CNS

1月4日提交，1月7号送审，1月25号minor revision.

59 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向：分子生物 经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801542, encodeId=94fd8015426a, content=我的15天了，还是submitted to the journal。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171966389, createdName=小张～医生, createdTime=Mon Jul 06 23:46:57 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=)]

2022-03-15 ms9000000615443695

偏重的研究方向：靶点;肝脏;药物
经验分享：今天刚投稿，期待与好的结果

49 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向：分子生物 经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801542, encodeId=94fd8015426a, content=我的15天了，还是submitted to the journal。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171966389, createdName=小张～医生, createdTime=Mon Jul 06 23:46:57 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=)]

2020-07-06 小张～医生

我的15天了，还是submitted to the journal。。。。。。

150 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向：分子生物 经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801542, encodeId=94fd8015426a, content=我的15天了，还是submitted to the journal。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171966389, createdName=小张～医生, createdTime=Mon Jul 06 23:46:57 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=)]

2021-11-16 山蛙

审稿速度:2.0 | 投稿命中率:25.0
经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。

99 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向：分子生物 经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801542, encodeId=94fd8015426a, content=我的15天了，还是submitted to the journal。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171966389, createdName=小张～医生, createdTime=Mon Jul 06 23:46:57 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

引言怎么写？

66 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向：分子生物 经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801542, encodeId=94fd8015426a, content=我的15天了，还是submitted to the journal。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171966389, createdName=小张～医生, createdTime=Mon Jul 06 23:46:57 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=)]

2021-12-27 MS54455111222

审稿人怎么利用关键词审稿？

87 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向：分子生物 经验分享：with editor 9天了还没有消息，大家的状态是多久啊这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了，投了三次都没送外审，果断放弃，应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢？ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？ginobily1 2017-12-07 18:54:00 发表: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了，还是With ethor，有大神知道什么情况吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188117, encodeId=c0fd118811ec2, content=1月4日提交，1月7号送审，1月25号minor revision., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78855431602, createdName=NJMU-CNS, createdTime=Tue Jan 25 21:04:34 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202767, encodeId=070d1202e674c, content=偏重的研究方向：靶点;肝脏;药物 经验分享：今天刚投稿，期待与好的结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a916553150, createdName=ms9000000615443695, createdTime=Tue Mar 15 15:06:06 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801542, encodeId=94fd8015426a, content=我的15天了，还是submitted to the journal。。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171966389, createdName=小张～医生, createdTime=Mon Jul 06 23:46:57 CST 2020, time=2020-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070677, encodeId=a56510e067742, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：CMLS是欧洲老牌期刊，对研究型论文要求很高，缺乏创新和深度的文章一般连外审的机会都没有！至于综述，通讯作者的研究履历是一个重要机会。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/26/41d1186db3b6c462bcb8e33954e97968.jpg, createdBy=a95e2575777, createdName=山蛙, createdTime=Tue Nov 16 09:33:51 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088502, encodeId=31fa10885023d, content=引言怎么写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088501, encodeId=867b1088501d0, content=审稿人怎么利用关键词审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970167, encodeId=7fa69e0167d4, content=需要交钱 3860美元。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc831937908, createdName=zzzzfffvvv, createdTime=Tue Jun 01 21:14:59 CST 2021, time=2021-06-01, status=1, ipAttribution=)]

2021-06-01 zzzzfffvvv

需要交钱 3860美元。

61 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务